Russia's EpiVacCorona Vaccine Develops Antibodies in 94% of Senior Citizens, Developer Says

MOSCOW (Sputnik) - As many as 94 percent of senior citizens develop antibodies against the coronavirus after being inoculated with Russia's EpiVacCorona vaccine, the head of the Yekaterinburg de